🇺🇸 FDA
Patent

US 11452691

Compositions of bupivacaine multivesicular liposomes

granted A61KA61K31/445A61K47/12

Quick answer

US patent 11452691 (Compositions of bupivacaine multivesicular liposomes) held by Pacira Pharmaceuticals, Inc. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Pacira Pharmaceuticals, Inc.
Grant date
Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
58
CPC classes
A61K, A61K31/445, A61K47/12, A61K47/14, A61K47/183